Endurant Capital Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-195,000
Closed -$2.08M 75
2020
Q4
$2.08M Buy
+195,000
New +$2.08M 0.75% 42